These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11368544)

  • 1. The food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline: a conformational analysis of its major DNA adduct and comparison with the 2-amino-3-methylimidazo[4,5-f]quinoline adduct.
    Gauvin J; Broyde S; Shapiro R
    Chem Res Toxicol; 2001 May; 14(5):476-82. PubMed ID: 11368544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of the major DNA adduct derived from the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline.
    Wu X; Shapiro R; Broyde S
    Chem Res Toxicol; 1999 Oct; 12(10):895-905. PubMed ID: 10525264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine.
    Turesky RJ; Rossi SC; Welti DH; Lay JO; Kadlubar FF
    Chem Res Toxicol; 1992; 5(4):479-90. PubMed ID: 1391614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence modulates the conformation of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in the recognition sequence of the NarI restriction enzyme.
    Wang F; Elmquist CE; Stover JS; Rizzo CJ; Stone MP
    Biochemistry; 2007 Jul; 46(29):8498-516. PubMed ID: 17602664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular mechanics and dynamics study of the minor adduct between DNA and the carcinogen 2-(acetylamino)fluorene (dG-N2-AAF).
    Grad R; Shapiro R; Hingerty BE; Broyde S
    Chem Res Toxicol; 1997 Oct; 10(10):1123-32. PubMed ID: 9348435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
    Thorgeirsson SS; Davis CD; Schut HA; Adamson RH; Snyderwine EG
    Princess Takamatsu Symp; 1995; 23():85-92. PubMed ID: 8844799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
    Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
    Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and quantification of DNA adducts of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in liver of rats by liquid chromatography/electrospray tandem mass spectrometry.
    Paehler A; Richoz J; Soglia J; Vouros P; Turesky RJ
    Chem Res Toxicol; 2002 Apr; 15(4):551-61. PubMed ID: 11952342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification.
    Pfau W; Brockstedt U; Söhren KD; Marquardt H
    Carcinogenesis; 1994 May; 15(5):877-82. PubMed ID: 8200090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Base-Displaced Intercalated Conformation of the 2-Amino-3-methylimidazo[4,5-f]quinoline N(2)-dG DNA Adduct Positioned at the Nonreiterated G(1) in the NarI Restriction Site.
    Stavros KM; Hawkins EK; Rizzo CJ; Stone MP
    Chem Res Toxicol; 2015 Jul; 28(7):1455-68. PubMed ID: 26083477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
    Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
    Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
    Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis.
    Schut HA; Snyderwine EG
    Carcinogenesis; 1999 Mar; 20(3):353-68. PubMed ID: 10190547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rapid human N-acetyltransferase 2 haplotype on DNA damage and mutagenesis induced by 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) and 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline (MeIQx).
    Metry KJ; Neale JR; Doll MA; Howarth AL; States JC; McGregor WG; Pierce WM; Hein DW
    Mutat Res; 2010 Feb; 684(1-2):66-73. PubMed ID: 20004212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.
    Turesky RJ; Parisod V; Huynh-Ba T; Langouët S; Guengerich FP
    Chem Res Toxicol; 2001 Jul; 14(7):901-11. PubMed ID: 11453738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450-mediated metabolism and DNA binding of 2-amino-1,7-dimethylimidazo[4,5-g]quinoxaline and its carcinogenic isomer 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice.
    Turesky RJ; Bessette EE; Dunbar D; Liberman RG; Skipper PL
    Chem Res Toxicol; 2012 Feb; 25(2):410-21. PubMed ID: 22118226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.
    Davis CD; Schut HA; Adamson RH; Thorgeirsson UP; Thorgeirsson SS; Snyderwine EG
    Carcinogenesis; 1993 Jan; 14(1):61-5. PubMed ID: 8425272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys.
    Snyderwine EG; Davis CD; Nouso K; Roller PP; Schut HA
    Carcinogenesis; 1993 Jul; 14(7):1389-95. PubMed ID: 8330355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational and DNA binding specificity of the carcinogen 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline.
    Solomon MS; Morgenthaler PM; Turesky RJ; Essigmann JM
    J Biol Chem; 1996 Aug; 271(31):18368-74. PubMed ID: 8702479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational differences of the C8-deoxyguanosine adduct of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) within the NarI recognition sequence.
    Elmquist CE; Wang F; Stover JS; Stone MP; Rizzo CJ
    Chem Res Toxicol; 2007 Mar; 20(3):445-54. PubMed ID: 17311423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.